Bio-Rad Laboratories Inc (BIO)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	-637,300	-159,300	-428,400	-191,214	-3,627,564	-6,027,464	-1,935,064	-93,150	4,254,200	6,665,600	4,050,800	4,100,400	3,806,300	3,520,600	1,947,000	1,579,400	1,758,700	376,700	904,800	574,000
Revenue (ttm)	US$ in thousands	2,637,846	2,686,946	2,731,337	2,741,910	2,774,598	2,777,098	2,856,467	2,894,713	2,922,702	2,979,702	2,876,119	2,701,076	2,540,271	2,374,971	2,288,622	2,311,881	2,292,289	2,284,689	2,267,881	2,271,474
Net profit margin		-24.16%	-5.93%	-15.68%	-6.97%	-130.74%	-217.04%	-67.74%	-3.22%	145.56%	223.70%	140.84%	151.81%	149.84%	148.24%	85.07%	68.32%	76.72%	16.49%	39.90%	25.27%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-637,300K ÷ $2,637,846K
= -24.16%

Net profit margin is a crucial financial metric that indicates the percentage of revenue that translates into actual profit after accounting for all expenses. A higher net profit margin suggests efficient cost management and profitability, while a lower margin could indicate challenges in controlling costs or generating revenue.

Based on the data provided for Bio-Rad Laboratories Inc., the net profit margin fluctuated significantly over the past eight quarters. The company experienced negative net profit margins in most quarters, with particularly alarming figures in Q4 of 2022 and Q3 of 2022, where the margins were -129.45% and -215.16% respectively.

These negative margins suggest that the company's expenses exceeded its revenue during those periods, resulting in net losses. Such drastic fluctuations and persistently negative margins raise concerns about the company's overall profitability and financial health.

In the most recent quarters, there has been some improvement in the net profit margins, with Q3 of 2023 showing a decrease in the negative margin to -5.64%. However, Q4 of 2023 still recorded a significant negative margin of -23.86%.

In conclusion, Bio-Rad Laboratories Inc. has been facing challenges in achieving positive net profit margins, with fluctuations indicating potential difficulties in managing costs and generating profits. Further analysis of the company's financial performance and strategic initiatives is warranted to address these issues and improve overall profitability.